Total Assets
McKesson Total Assets decreased by 2.2% to $82.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.6%, from $75.14B to $82.32B. Over 5 years (FY 2021 to FY 2026), Total Assets shows an upward trend with a 4.8% CAGR.
Analysis
How to read this metric
An increase suggests business expansion or capital investment, while a decrease may indicate asset divestiture or downsizing.
Detailed definition
Total assets represent the aggregate value of all current and non-current resources owned by the company, including cash...
Peer comparison
Standard across all industries; peers in pharmaceutical distribution typically show high asset bases due to large inventory requirements.
total_assetsHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.89B | $63.6B | $63.71B | $63.3B | $62.3B | $63.08B | $62.69B | $62.32B | $64.1B | $66.09B | $66.51B | $67.44B | $71.67B | $72.43B | $71.08B | $75.14B | $81.31B | $84.16B | $84.19B | $82.32B |
| QoQ Change | — | +1.1% | +0.2% | -0.6% | -1.6% | +1.3% | -0.6% | -0.6% | +2.8% | +3.1% | +0.6% | +1.4% | +6.3% | +1.1% | -1.9% | +5.7% | +8.2% | +3.5% | +0.0% | -2.2% |
| YoY Change | — | — | — | — | -1.0% | -0.8% | -1.6% | -1.5% | +2.9% | +4.8% | +6.1% | +8.2% | +11.8% | +9.6% | +6.9% | +11.4% | +13.5% | +16.2% | +18.4% | +9.6% |
Business Segments
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 |
|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | $38.35B | — | — | — | $41.79B | $46.81B |
| International | $13.72B | $10.9B | $9.6B | $6.2B | $6.23B | $6.54B |
| Medical-Surgical Solutions | $5.83B | — | — | — | $5.78B | $6.23B |
| Prescription Technology Solutions | — | — | — | — | $4.17B | — |
| Total | $63.3B | $62.3B | $63.08B | $62.69B | $62.32B | $67.44B |
International, Medical-Surgical Solutions, Prescription Technology Solutions, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Assets at Other Companies
Frequently Asked Questions
- What is McKesson's total assets?
- McKesson (MCK) reported total assets of $82.32B in Q1 2026.
- How has McKesson's total assets changed year-over-year?
- McKesson's total assets increased by 9.6% year-over-year, from $75.14B to $82.32B.
- What is the long-term trend for McKesson's total assets?
- Over 5 years (2021 to 2026), McKesson's total assets has grown at a 4.8% compound annual growth rate (CAGR), from $65.02B to $82.32B.
- What does total assets mean?
- The total value of everything the company owns.